BioCryst Pharmaceuticals Inc.
BCRX | NASDAQ
$8.96
+$0.20 (+2.28%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 218.25M | 156.41M | 406.56M | 159.4M | 163.35M | 145.53M | 131.53M | 117.09M | 109.33M | 92.76M | 93.4M | 86.74M | 82.49M | 68.78M | 79.55M | 75.83M | 65.53M | 49.92M | 47.16M | 40.99M | 49.96M | 19.06M |
Cost of Revenue | 3.84M | 703.14M | 9.92M | 2.52M | 2.8M | 4.57M | 6.13M | 3.23M | 1.7M | 1.27M | 1.64M | 1.14M | 950K | 938K | 2.5M | 3.61M | 247K | 238K | 419K | 615K | 343K | 5.92M |
Gross Profit | 214.41M | -546.73M | 396.64M | 156.87M | 160.56M | 140.97M | 125.4M | 113.86M | 107.63M | 91.5M | 91.76M | 85.61M | 81.54M | 67.84M | 77.05M | 72.21M | 65.29M | 49.69M | 46.74M | 40.38M | 49.62M | 13.14M |
Operating Income | 98.47M | -701.6M | 260.39M | 29.59M | 29.79M | 21.23M | -4.51M | 7.69M | 8.76M | -14.49M | -42.67M | -11.92M | -20.7M | -28.42M | -46.31M | -17.45M | -34.72M | -49.96M | -52.18M | -44.58M | -29.58M | -51.38M |
Interest Income | 2.43M | 2.26M | 2.89M | 2.24M | 2.52M | 3.02M | 3.57M | 3.59M | 3.55M | 4.03M | 4.47M | 4.18M | 3.75M | 3.38M | 2.7M | 1.76M | 609K | 54K | 14K | 9K | 13K | 26K |
Pretax Income | 79.47M | -720.81M | 248.02M | 12.13M | 6.49M | 758K | -25.99M | -13.45M | -12.5M | -35.01M | -63.16M | -35.82M | -74.59M | -52.66M | -71.47M | -41M | -58M | -73.92M | -15.53M | -58.8M | -43.2M | -64.28M |
Net Income | 78.4M | -721.81M | 245.85M | 12.9M | 5.09M | 32K | -26.8M | -14.03M | -12.67M | -35.38M | -61.73M | -36.15M | -75.33M | -53.33M | -71.54M | -42.52M | -58.86M | -74.2M | -17.78M | -58.8M | -43.2M | -64.28M |
Selling & General & Admin | 63.98M | 94.55M | 95.78M | 83.01M | 87.38M | 82.47M | 80.47M | 65.08M | 61.25M | 59.49M | 64.38M | 50.65M | 51M | 47.87M | 50.15M | 36.92M | 38.02M | 34.28M | 35.39M | 34.99M | 26.33M | 22.11M |
Research & Development | 51.97M | 60.32M | 41.2M | 44.27M | 43.39M | 37.27M | 49.44M | 41.08M | 37.62M | 46.49M | 70.05M | 46.88M | 51.25M | 48.39M | 73.21M | 52.74M | 61.99M | 65.36M | 63.53M | 49.97M | 52.87M | 42.44M |
Other Expenses | n/a | n/a | -335K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -36K |
Operating Expenses | 115.95M | 154.87M | 136.65M | 127.28M | 130.77M | 119.74M | 129.91M | 106.17M | 98.87M | 105.98M | 134.43M | 97.53M | 102.24M | 96.26M | 123.36M | 89.66M | 100.01M | 99.64M | 98.92M | 84.96M | 79.2M | 64.51M |
Interest Expense | 21.71M | 19.78M | 14.14M | 19.66M | 21.58M | 23.49M | 24.45M | 24.83M | 24.73M | 24.51M | 24.58M | 27.35M | 28.92M | 27.4M | 26.46M | 24.78M | 24.02M | 23.84M | 18.78M | 14.12M | 13.5M | 12.9M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.1M | 3.98M | 1.01M | 1.49M | 1.8M | 1.4M |
Cost & Expenses | 119.79M | 858.01M | 146.17M | 129.8M | 133.57M | 124.31M | 136.04M | 109.39M | 100.57M | 107.25M | 136.07M | 98.66M | 103.19M | 97.19M | 125.86M | 93.27M | 100.25M | 99.88M | 99.34M | 85.58M | 79.54M | 70.44M |
Income Tax Expense | 1.08M | 1M | 2.17M | -769K | 1.4M | 726K | 804K | 586K | 172K | 365K | -1.43M | 330K | 740K | 671K | 76K | 1.52M | 856K | 279K | 2.25M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 254.48M | 242.26M | 210.97M | 210.18M | 209.52M | 208.88M | 207.38M | 206.91M | 206.43M | 206.06M | 201.41M | 189.64M | 189.12M | 188.51M | 186.92M | 186.18M | 183.93M | 184.9M | 181.84M | 179.11M | 178.13M | 177.34M |
Shares Outstanding (Diluted) | 265.17M | 242.26M | 219.26M | 219.89M | 219.89M | 215.26M | 207.38M | 206.91M | 206.43M | 206.06M | 201.41M | 189.64M | 189.12M | 188.51M | 186.92M | 186.18M | 185.61M | 184.9M | 181.84M | 179.11M | 178.13M | 177.34M |
EPS (Basic) | 0.31 | -2.98 | 1.17 | 0.06 | 0.02 | n/a | -0.13 | -0.07 | -0.06 | -0.17 | -0.31 | -0.19 | -0.40 | -0.28 | -0.38 | -0.23 | -0.32 | -0.40 | -0.10 | -0.33 | -0.24 | -0.36 |
EPS (Diluted) | 0.30 | -2.98 | 1.12 | 0.06 | 0.02 | n/a | -0.13 | -0.07 | -0.06 | -0.17 | -0.31 | -0.19 | -0.40 | -0.28 | -0.38 | -0.23 | -0.32 | -0.40 | -0.10 | -0.33 | -0.24 | -0.36 |
EBITDA | 98.78M | -699.97M | 266.2M | 32.13M | 28.4M | 24.58M | -1.23M | 11.69M | 12.55M | -10.2M | -38.16M | -8.05M | -45.26M | -24.86M | -44.61M | -15.83M | -33.65M | -49.76M | 3.43M | -44.46M | -29.5M | -51.2M |
EBIT | 98.18M | -701.03M | 262.15M | 31.79M | 28.07M | 24.25M | -1.54M | 11.38M | 12.23M | -10.51M | -38.58M | -8.47M | -45.67M | -25.27M | -45.01M | -16.22M | -33.98M | -50.08M | 3.25M | -44.69M | -29.7M | -51.38M |
Depreciation & Amortization | 600K | 1.06M | 4.04M | 335K | 329K | 331K | 309K | 311K | 320K | 306K | 423K | 420K | 407K | 405K | 396K | 389K | 335K | 317K | 171K | 229K | 199K | 178K |
Add to Watchlist
Select watchlists to add or remove BCRX